| 0 |
ACQUIRED PROTEIN S DEFICIENCY |
1 |
0.0909 |
| 1 |
CANNABIS INTERACTION |
1 |
0.0769 |
| 2 |
MAGNETIC RESONANCE IMAGING SPINAL ABNORMAL |
3 |
0.0246 |
| 3 |
VIBRATION SYNDROME |
1 |
0.0217 |
| 4 |
TYPE 3 DIABETES MELLITUS |
1 |
0.0147 |
| 5 |
FAT REDISTRIBUTION |
1 |
0.0043 |
| 6 |
SARS-COV-2 ANTIBODY TEST NEGATIVE |
2 |
0.0042 |
| 7 |
NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED |
1 |
0.0037 |
| 8 |
BONE CONTUSION |
3 |
0.0033 |
| 9 |
CYSTITIS NONINFECTIVE |
4 |
0.0030 |
| 10 |
GASTROINTESTINAL MICROORGANISM OVERGROWTH |
1 |
0.0028 |
| 11 |
NONINFECTIVE GINGIVITIS |
4 |
0.0028 |
| 12 |
ENDOMETRIAL HYPERPLASIA |
2 |
0.0025 |
| 13 |
DIPLEGIA |
3 |
0.0015 |
| 14 |
DIARRHOEA INFECTIOUS |
1 |
0.0013 |
| 15 |
DYSBIOSIS |
1 |
0.0012 |
| 16 |
VACCINATION FAILURE |
2 |
0.0012 |
| 17 |
PREMATURE MENOPAUSE |
1 |
0.0011 |
| 18 |
ESSENTIAL TREMOR |
1 |
0.0009 |
| 19 |
THERAPEUTIC PRODUCT EFFECT INCREASED |
1 |
0.0009 |
| 20 |
COLON OPERATION |
1 |
0.0008 |
| 21 |
ESCHERICHIA TEST POSITIVE |
1 |
0.0008 |
| 22 |
B-LYMPHOCYTE COUNT DECREASED |
1 |
0.0007 |
| 23 |
PANCREATIC ENZYMES INCREASED |
1 |
0.0007 |
| 24 |
SKIN ABRASION |
3 |
0.0006 |
| 25 |
OPHTHALMOPLEGIA |
1 |
0.0006 |
| 26 |
GASTRIC DILATATION |
1 |
0.0006 |
| 27 |
BLOOD IMMUNOGLOBULIN G DECREASED |
1 |
0.0004 |
| 28 |
RED BLOOD CELL COUNT INCREASED |
1 |
0.0004 |
| 29 |
PULMONARY PAIN |
1 |
0.0003 |
| 30 |
IMMUNOSUPPRESSION |
3 |
0.0003 |
| 31 |
CORONAVIRUS INFECTION |
2 |
0.0003 |
| 32 |
APPENDICECTOMY |
1 |
0.0003 |
| 33 |
BONE LESION |
1 |
0.0003 |
| 34 |
CERVIX CARCINOMA |
1 |
0.0003 |
| 35 |
INTRACRANIAL ANEURYSM |
1 |
0.0002 |
| 36 |
TRIGEMINAL NEURALGIA |
1 |
0.0002 |
| 37 |
GINGIVAL SWELLING |
1 |
0.0002 |
| 38 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 39 |
GASTRITIS EROSIVE |
1 |
0.0002 |
| 40 |
LIGAMENT SPRAIN |
2 |
0.0002 |
| 41 |
PARTIAL SEIZURES |
1 |
0.0002 |
| 42 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 43 |
MALNUTRITION |
2 |
0.0002 |
| 44 |
HYPERTRIGLYCERIDAEMIA |
1 |
0.0002 |
| 45 |
PLATELET COUNT ABNORMAL |
1 |
0.0002 |
| 46 |
ADRENAL INSUFFICIENCY |
2 |
0.0002 |
| 47 |
SECRETION DISCHARGE |
2 |
0.0002 |
| 48 |
TENDON DISORDER |
1 |
0.0002 |
| 49 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
1 |
0.0001 |
| 50 |
LYMPHOEDEMA |
1 |
0.0001 |
| 51 |
FORMICATION |
1 |
0.0001 |
| 52 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 53 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 54 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 55 |
SECOND PRIMARY MALIGNANCY |
1 |
0.0001 |
| 56 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 57 |
COLD SWEAT |
2 |
0.0001 |
| 58 |
BLOOD TRIGLYCERIDES INCREASED |
2 |
0.0001 |
| 59 |
CARDIOTOXICITY |
1 |
0.0001 |
| 60 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 61 |
TOOTHACHE |
2 |
0.0001 |
| 62 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 63 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
| 64 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 65 |
BODY TEMPERATURE DECREASED |
1 |
0.0001 |
| 66 |
BLADDER DISORDER |
1 |
0.0001 |
| 67 |
FEEDING DISORDER |
2 |
0.0001 |
| 68 |
BODY TEMPERATURE INCREASED |
2 |
0.0001 |
| 69 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 70 |
EYE DISCHARGE |
1 |
0.0001 |
| 71 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 72 |
SCRATCH |
1 |
0.0001 |
| 73 |
TOOTH FRACTURE |
1 |
0.0001 |
| 74 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 75 |
INFLUENZA LIKE ILLNESS |
7 |
0.0001 |
| 76 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 77 |
TOOTH EXTRACTION |
1 |
0.0001 |
| 78 |
BRAIN OEDEMA |
1 |
0.0001 |
| 79 |
NODULE |
1 |
0.0001 |
| 80 |
BEDRIDDEN |
1 |
0.0001 |
| 81 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 82 |
PERIPHERAL COLDNESS |
1 |
0.0001 |
| 83 |
BRONCHOSPASM |
1 |
0.0001 |
| 84 |
PARALYSIS |
1 |
0.0001 |
| 85 |
IMPAIRED QUALITY OF LIFE |
1 |
0.0001 |
| 86 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 87 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 88 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 89 |
COVID-19 |
11 |
0.0001 |
| 90 |
MUSCLE TIGHTNESS |
1 |
0.0001 |
| 91 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 92 |
ECZEMA |
3 |
0.0001 |
| 93 |
MUSCULOSKELETAL STIFFNESS |
5 |
0.0001 |
| 94 |
BURNING SENSATION |
4 |
0.0001 |
| 95 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 96 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 97 |
C-REACTIVE PROTEIN INCREASED |
2 |
0.0001 |
| 98 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 99 |
BLISTER |
3 |
0.0001 |
| 100 |
COLITIS |
2 |
0.0001 |
| 101 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 102 |
INCREASED APPETITE |
1 |
0.0001 |
| 103 |
CHILLS |
6 |
0.0001 |
| 104 |
PSORIATIC ARTHROPATHY |
2 |
0.0000 |
| 105 |
TOOTH LOSS |
1 |
0.0000 |
| 106 |
DERMATITIS |
1 |
0.0000 |
| 107 |
KNEE ARTHROPLASTY |
1 |
0.0000 |
| 108 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 109 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 110 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 111 |
AMNESIA |
3 |
0.0000 |
| 112 |
TOOTH DISORDER |
1 |
0.0000 |
| 113 |
GLOSSODYNIA |
1 |
0.0000 |
| 114 |
MUSCULAR WEAKNESS |
5 |
0.0000 |
| 115 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 116 |
CHEST PAIN |
8 |
0.0000 |
| 117 |
BLOOD CHOLESTEROL INCREASED |
2 |
0.0000 |
| 118 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 119 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 120 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 121 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 122 |
LUNG DISORDER |
2 |
0.0000 |
| 123 |
CELLULITIS |
2 |
0.0000 |
| 124 |
PERIPHERAL SWELLING |
6 |
0.0000 |
| 125 |
DIPLOPIA |
1 |
0.0000 |
| 126 |
ARTHRITIS |
3 |
0.0000 |
| 127 |
JOINT STIFFNESS |
1 |
0.0000 |
| 128 |
PAIN OF SKIN |
1 |
0.0000 |
| 129 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 130 |
OEDEMA |
2 |
0.0000 |
| 131 |
SKIN LESION |
1 |
0.0000 |
| 132 |
ARTHROPATHY |
2 |
0.0000 |
| 133 |
FEELING COLD |
1 |
0.0000 |
| 134 |
WOUND |
1 |
0.0000 |
| 135 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 136 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 137 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 138 |
ANGINA PECTORIS |
1 |
0.0000 |
| 139 |
LETHARGY |
2 |
0.0000 |
| 140 |
DYSSTASIA |
1 |
0.0000 |
| 141 |
SURGERY |
2 |
0.0000 |
| 142 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 143 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 144 |
SWELLING |
3 |
0.0000 |
| 145 |
PARAESTHESIA |
5 |
0.0000 |
| 146 |
NEUROPATHY PERIPHERAL |
3 |
0.0000 |
| 147 |
GAIT DISTURBANCE |
6 |
0.0000 |
| 148 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 149 |
CHOLELITHIASIS |
1 |
0.0000 |
| 150 |
IMPAIRED HEALING |
1 |
0.0000 |
| 151 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 152 |
SKIN DISORDER |
1 |
0.0000 |
| 153 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 154 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 155 |
ABDOMINAL PAIN UPPER |
6 |
0.0000 |
| 156 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 157 |
LYMPHADENOPATHY |
1 |
0.0000 |
| 158 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 159 |
PAIN IN EXTREMITY |
8 |
0.0000 |
| 160 |
NASOPHARYNGITIS |
5 |
0.0000 |
| 161 |
HYPOAESTHESIA |
4 |
0.0000 |
| 162 |
FATIGUE |
20 |
0.0000 |
| 163 |
BLINDNESS |
1 |
0.0000 |
| 164 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 165 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 166 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 167 |
THROAT IRRITATION |
1 |
0.0000 |
| 168 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 169 |
MUSCLE SPASMS |
4 |
0.0000 |
| 170 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 171 |
WEIGHT DECREASED |
6 |
0.0000 |
| 172 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 173 |
ASTHENIA |
8 |
0.0000 |
| 174 |
FALL |
7 |
0.0000 |
| 175 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 176 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 177 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 178 |
INFECTION |
3 |
0.0000 |
| 179 |
ALOPECIA |
4 |
0.0000 |
| 180 |
HYPOTENSION |
4 |
0.0000 |
| 181 |
ILLNESS |
2 |
0.0000 |
| 182 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 183 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 184 |
PANCREATITIS |
1 |
0.0000 |
| 185 |
BRADYCARDIA |
1 |
0.0000 |
| 186 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 187 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 188 |
WHITE BLOOD CELL COUNT DECREASED |
2 |
0.0000 |
| 189 |
NECK PAIN |
1 |
0.0000 |
| 190 |
WEIGHT INCREASED |
4 |
0.0000 |
| 191 |
ASTHMA |
2 |
0.0000 |
| 192 |
FLATULENCE |
1 |
0.0000 |
| 193 |
HERPES ZOSTER |
1 |
0.0000 |
| 194 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 195 |
SEIZURE |
2 |
0.0000 |
| 196 |
BACK PAIN |
4 |
0.0000 |
| 197 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 198 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 199 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 200 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 201 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 202 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 203 |
VOMITING |
7 |
0.0000 |
| 204 |
NEUTROPENIA |
2 |
0.0000 |
| 205 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 206 |
VISION BLURRED |
2 |
0.0000 |
| 207 |
HEADACHE |
9 |
0.0000 |
| 208 |
COUGH |
4 |
0.0000 |
| 209 |
SLEEP DISORDER |
1 |
0.0000 |
| 210 |
DIZZINESS |
7 |
0.0000 |
| 211 |
DIARRHOEA |
9 |
0.0000 |
| 212 |
MOBILITY DECREASED |
1 |
0.0000 |
| 213 |
UNDERDOSE |
1 |
0.0000 |
| 214 |
AGITATION |
1 |
0.0000 |
| 215 |
HOT FLUSH |
1 |
0.0000 |
| 216 |
DEPRESSION |
3 |
0.0000 |
| 217 |
DIABETES MELLITUS |
1 |
0.0000 |
| 218 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 219 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 220 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 221 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 222 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 223 |
FEELING ABNORMAL |
3 |
0.0000 |
| 224 |
CARDIAC FAILURE |
1 |
0.0000 |
| 225 |
DYSPNOEA |
7 |
0.0000 |
| 226 |
TREMOR |
2 |
0.0000 |
| 227 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 228 |
URTICARIA |
2 |
0.0000 |
| 229 |
MYALGIA |
2 |
0.0000 |
| 230 |
URINARY TRACT INFECTION |
2 |
0.0000 |
| 231 |
PYREXIA |
4 |
0.0000 |
| 232 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 233 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 234 |
INSOMNIA |
3 |
0.0000 |
| 235 |
MATERNAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 236 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 237 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 238 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 239 |
DYSPHAGIA |
1 |
0.0000 |
| 240 |
MIGRAINE |
1 |
0.0000 |
| 241 |
CONTUSION |
1 |
0.0000 |
| 242 |
DYSPEPSIA |
1 |
0.0000 |
| 243 |
NAUSEA |
8 |
0.0000 |
| 244 |
HEART RATE INCREASED |
1 |
0.0000 |
| 245 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
2 |
0.0000 |
| 246 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 247 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 248 |
PNEUMONIA |
3 |
0.0000 |
| 249 |
CONSTIPATION |
2 |
0.0000 |
| 250 |
MALAISE |
4 |
0.0000 |
| 251 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 252 |
PALPITATIONS |
1 |
0.0000 |
| 253 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 254 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 255 |
PAIN |
5 |
0.0000 |
| 256 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 257 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 258 |
DEHYDRATION |
1 |
0.0000 |
| 259 |
ARTHRALGIA |
3 |
0.0000 |
| 260 |
ANXIETY |
2 |
0.0000 |
| 261 |
RASH |
3 |
0.0000 |
| 262 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 263 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 264 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 265 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 266 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 267 |
PRURITUS |
2 |
0.0000 |
| 268 |
SOMNOLENCE |
1 |
0.0000 |
| 269 |
ERYTHEMA |
1 |
0.0000 |
| 270 |
HYPERTENSION |
1 |
0.0000 |
| 271 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 272 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 273 |
OFF LABEL USE |
3 |
0.0000 |
| 274 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 275 |
DRUG INEFFECTIVE |
4 |
0.0000 |
| 276 |
DEATH |
2 |
0.0000 |